Lee's Pharma acquires Staccato inhalation tech from Alexza, gaining IP, facility, and pipeline assets for CNS drug development.

Southern Illinois Healthcare now offers 30+ cancer trials, including a global Phase III lung cancer study, enabling rural patients access to advanced treatments locally.

China will cover Leqembi for early Alzheimer’s via private insurance starting Jan 1, 2026.

Structure Therapeutics shares hit a 52-week high after its weight loss drug showed 15.3% average weight loss in trials.

Singapore-MIT launches wearable ultrasound patch for home monitoring of heart and lung conditions.

A new antibody therapy eliminated detectable multiple myeloma in all 18 trial patients, showing potential for a functional cure.

Northwestern researchers created a wireless brain implant that lets mice interpret artificial signals via light, enabling decision-making without sight, sound, or touch.

Dr Reddy’s gains rights to sell Immutep’s cancer drug outside key markets in deal up to $349.5M.

Sanofi gains two Chinese drug approvals: Qfitlia for hemophilia prevention and Cablivi for a rare blood clotting disorder.

India's Delhi High Court lets Dr. Reddy’s export semaglutide to patent-free countries, rejecting Novo Nordisk’s appeal.